Phibro Animal Health (NASDAQ:PAHC) Price Target Lowered to $17.00 at Morgan Stanley

Phibro Animal Health (NASDAQ:PAHCFree Report) had its target price trimmed by Morgan Stanley from $18.00 to $17.00 in a research report released on Thursday, Marketbeat Ratings reports. The firm currently has an equal weight rating on the stock.

Other analysts also recently issued reports about the stock. raised shares of Phibro Animal Health from a hold rating to a buy rating in a report on Friday, August 25th. Roth Mkm restated a buy rating and set a $21.00 price target on shares of Phibro Animal Health in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of Hold and a consensus price target of $18.25.

View Our Latest Research Report on PAHC

Phibro Animal Health Price Performance

NASDAQ PAHC opened at $13.95 on Thursday. The firm has a market cap of $564.98 million, a P/E ratio of 19.65, a price-to-earnings-growth ratio of 7.32 and a beta of 0.62. The stock’s 50-day moving average is $14.60 and its two-hundred day moving average is $14.73. Phibro Animal Health has a fifty-two week low of $11.75 and a fifty-two week high of $16.52. The company has a debt-to-equity ratio of 1.71, a current ratio of 3.54 and a quick ratio of 1.77.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last issued its quarterly earnings data on Thursday, August 31st. The company reported $0.38 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.02). The company had revenue of $255.00 million during the quarter, compared to the consensus estimate of $256.68 million. Phibro Animal Health had a net margin of 2.92% and a return on equity of 18.13%. During the same period in the previous year, the business posted $0.36 earnings per share. On average, analysts anticipate that Phibro Animal Health will post 1.23 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 3.44%. The ex-dividend date is Tuesday, September 5th. Phibro Animal Health’s payout ratio is currently 67.61%.

Institutional Trading of Phibro Animal Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Comerica Bank bought a new stake in shares of Phibro Animal Health in the second quarter valued at about $3,877,000. Alliancebernstein L.P. raised its holdings in Phibro Animal Health by 3.4% in the 2nd quarter. Alliancebernstein L.P. now owns 26,630 shares of the company’s stock valued at $365,000 after acquiring an additional 880 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Phibro Animal Health by 1.0% in the 2nd quarter. Wells Fargo & Company MN now owns 206,345 shares of the company’s stock worth $2,827,000 after acquiring an additional 2,041 shares during the period. Connors Investor Services Inc. grew its holdings in shares of Phibro Animal Health by 15.3% during the 2nd quarter. Connors Investor Services Inc. now owns 15,101 shares of the company’s stock worth $207,000 after purchasing an additional 2,000 shares in the last quarter. Finally, Royal Bank of Canada increased its position in shares of Phibro Animal Health by 8.8% during the second quarter. Royal Bank of Canada now owns 9,188 shares of the company’s stock valued at $127,000 after purchasing an additional 745 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Further Reading

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with's FREE daily email newsletter.